-
公开(公告)号:IE921658A1
公开(公告)日:1992-12-02
申请号:IE921658
申请日:1992-07-01
Applicant: HOECHST AG
Inventor: DANIELISOVA VIERA , KOLVENBACH RALF , SCHUBERT HANS-PETER , GROME JOHN , SCHNEIDER ERNST JURGEN
IPC: A61K31/52 , A61K31/522 , A61P25/00 , A61P25/28 , C07D473/06
Abstract: The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine or of physiologically tolerated salts of this compound for the production of pharmaceuticals for the prophylaxis and treatment of nerve damage after interruption of the blood circulation.
-
公开(公告)号:PT97329A
公开(公告)日:1992-01-31
申请号:PT9732991
申请日:1991-04-11
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , ANAGNOSTOPULOS HIRISTO , PORSCHE-WIEBKING ELENA , GROME JOHN
IPC: A61K31/415 , A61K31/44 , A61K31/445 , A61K31/675 , A61P9/10 , A61P25/08 , A61P25/18 , A61P25/28 , C07D261/04 , C07D261/08 , C07D261/12 , C07D261/18 , C07D413/04 , C07D413/06 , C07F9/653 , C07D261/00 , C07D413/00 , A61K31/42
Abstract: Novel 3,5-disubstituted 2-isoxazolines and isoxazoles and novel pharmaceuticals are described which are suitable, in particular, for the prophylaxis and/or treatment of pathological, neurodegenerative disorders in humans and animals. Processes for the preparation of these 3,5-disubstituted 2-isoxazolines and isoxazolines and isoxazoles are additionally indicated.
-
公开(公告)号:AU7428591A
公开(公告)日:1991-10-17
申请号:AU7428591
申请日:1991-04-11
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , ANAGNOSTOPULOS HIRISTO , PORSCHE-WIEBKING ELENA , GROME JOHN
IPC: A61K31/415 , A61K31/44 , A61K31/445 , A61K31/675 , A61P9/10 , A61P25/08 , A61P25/18 , A61P25/28 , C07D261/04 , C07D261/08 , C07D261/12 , C07D261/18 , C07D413/04 , C07D413/06 , C07F9/653 , A61K31/42
Abstract: Novel 3,5-disubstituted 2-isoxazolines and isoxazoles and novel pharmaceuticals are described which are suitable, in particular, for the prophylaxis and/or treatment of pathological, neurodegenerative disorders in humans and animals. Processes for the preparation of these 3,5-disubstituted 2-isoxazolines and isoxazolines and isoxazoles are additionally indicated.
-
公开(公告)号:FI911718A
公开(公告)日:1991-10-13
申请号:FI911718
申请日:1991-04-10
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , ANAGNOSTOPULOS HIRISTO , PORSCHE-WIEBKING ELENA , GROME JOHN
IPC: A61K31/415 , A61K31/44 , A61K31/445 , A61K31/675 , A61P9/10 , A61P25/08 , A61P25/18 , A61P25/28 , C07D261/04 , C07D261/08 , C07D261/12 , C07D261/18 , C07D413/04 , C07D413/06 , C07F9/653 , C07D
Abstract: Novel 3,5-disubstituted 2-isoxazolines and isoxazoles and novel pharmaceuticals are described which are suitable, in particular, for the prophylaxis and/or treatment of pathological, neurodegenerative disorders in humans and animals. Processes for the preparation of these 3,5-disubstituted 2-isoxazolines and isoxazolines and isoxazoles are additionally indicated.
-
公开(公告)号:CA2040219A1
公开(公告)日:1991-10-13
申请号:CA2040219
申请日:1991-04-11
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , ANAGNOSTOPULOS HIRISTO , PORSCHE-WIEBKING ELENA , GROME JOHN
IPC: A61K31/415 , A61K31/44 , A61K31/445 , A61K31/675 , A61P9/10 , A61P25/08 , A61P25/18 , A61P25/28 , C07D261/04 , C07D261/08 , C07D261/12 , C07D261/18 , C07D413/04 , C07D413/06 , C07F9/653 , C07D261/00 , A61K31/42
Abstract: - 1 - HOE 90/F 111 of the disclosure 3,5-Disubstituted 2-isoxazolines and isoxazoles, processes for their preparation, agents containing them and their use Novel 3,5-disubstituted 2-isoxazolines and isoxazoles and novel pharmaceuticals are described which are suitable, in particular, for the prophylaxis and/or treatment of pathological, neurodegenerative disorders in humans and animals. Processes for the preparation of these 3,5disubstituted 2-isoxazolines and isoxazoles are additionally indicated.
-
公开(公告)号:CA2085046A1
公开(公告)日:1993-06-12
申请号:CA2085046
申请日:1992-12-10
Applicant: HOECHST AG
Inventor: KOLVENBACH RALF , GROME JOHN , SCHNEIDER ERNST J
IPC: A61K31/52 , A61K31/522 , A61P9/00 , C07D473/04
Abstract: HOE 91/F 384 The use of xanthine derivatives for stabilizing autoregulation of cerebral circulation. The use of at least one xanthine derivative of the formula I (I) and/or of at least one physiologically tolerable salt of the formula I in which R1 is oxoalkyl, hydroxyalkyl or alkyl, R2 is a hydrogen atom or alkyl and R3 is a hydrogen atom, alkyl, oxoalkyl or an alkyl having up to 6 carbon atoms, whose carbon chain is interrupted by an oxygen atom, for the production of pharmaceuticals for stabilizing autoregulation of cerebral circulation, and cerebral protection during cardiac or pulmonary resuscitation is described.
-
公开(公告)号:MX9207156A
公开(公告)日:1993-06-01
申请号:MX9207156
申请日:1992-12-10
Applicant: HOECHST AG
Inventor: KOLVENBACH ROLF , GROME JOHN , SCHNEIDER ERNST-JURGEN
IPC: A61K31/52 , A61K31/522 , A61P9/00 , C07D473/04
Abstract: The use of at least one xanthine derivative of the formula I, and/or of at least one physiologically tolerated salt of the formula I, where R is oxoalkyl, hydroxyalkyl or alkyl, R is hydrogen atom or alkyl and R is hydrogen atom, alkyl, oxoalkyl or an alkyl with up to 6 carbon atoms whose carbon chain is interrupted by an oxygen atom, for the preparation of pharmaceutical compositions for the stabilisation of the autoregulation of cerebral blood flow, as well as cerebral protection during cardiac or pulmonary resuscitation, is described.
-
公开(公告)号:HUT61469A
公开(公告)日:1993-01-28
申请号:HU9201695
申请日:1992-05-21
Applicant: HOECHST AG
Inventor: DANIELISOVA VIELA , KOLVENBACH RALF , SCHUBERT HANS-PETER , GROME JOHN , SCHNEIDER ERNST JUERGEN
IPC: A61K31/52 , A61K31/522 , A61P25/00 , A61P25/28 , C07D473/06
Abstract: The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine or of physiologically tolerated salts of this compound for the production of pharmaceuticals for the prophylaxis and treatment of nerve damage after interruption of the blood circulation.
-
公开(公告)号:CA2069202A1
公开(公告)日:1992-11-24
申请号:CA2069202
申请日:1992-05-22
Applicant: HOECHST AG
Inventor: DANIELISOVA VIERA , KOLVENBACH RALF , SCHUBERT HANS-PETER , GROME JOHN , SCHNEIDER ERNST J
IPC: A61K31/52 , A61K31/522 , A61P25/00 , A61P25/28 , C07D473/06
Abstract: of the disclosure: The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine or of physiologically tolerated salts of this compound for the preparation of pharmaceuticals for the prophylaxis and treatment of nerve damage after interruption of the blood circulation.
-
公开(公告)号:NO911432A
公开(公告)日:1991-10-14
申请号:NO911432
申请日:1991-04-11
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , ANAGNOSTOPULOS HIRISTO , PORSCHE-WIEBKING ELENA , GROME JOHN
IPC: A61K31/415 , A61K31/44 , A61K31/445 , A61K31/675 , A61P9/10 , A61P25/08 , A61P25/18 , A61P25/28 , C07D261/04 , C07D261/08 , C07D261/12 , C07D261/18 , C07D413/04 , C07D413/06 , C07F9/653
CPC classification number: C07D413/04 , C07D261/04 , C07D261/08 , C07D261/18 , C07F9/653
-
-
-
-
-
-
-
-
-